BIOX
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 15 | -4 | 2.45M | $856,109 | — | −4 |
| Q1 2026 | 19 | -4 | 3.24M | $1.44M | +1 | −5 |
| Q4 2025 | 23 | +1 | 2.87M | $3.76M | +2 | −1 |
| Q3 2025 | 6 | +1 | 441.34K | $622,292 | +1 | — |
| Q2 2025 | 2 | 0 | 153.98K | $688,285 | — | — |
| Q1 2025 | 2 | 0 | 94.59K | $431,784 | — | — |
| Q4 2024 | 2 | -3 | 153.44K | $932,939 | — | −3 |
| Q3 2024 | 5 | +1 | 395.03K | $3.11M | +1 | — |
| Q2 2024 | 4 | — | 330.19K | $3.70M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 55.66K | -51.4% | $254,083 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 38.93K | 0.0% | $177,701 | 0.0% | Held | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 31 holders, 9.25M shares, $4.10M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.